Staff at one plant hid documents and poured samples down sinks, inspection reports show. Both suppliers of compounded semaglutide and tirzepatide are now on FDA import alert.
Recap by typeshit. Full story at Los Angeles Times.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
A fresh warning points to more people ending up in hospital after taking peptides that aren't approved. Tap through for who issued it.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
Loading…